Gori, Niccolo'
 Distribuzione geografica
Continente #
NA - Nord America 356
EU - Europa 173
AS - Asia 45
AF - Africa 9
SA - Sud America 4
OC - Oceania 1
Totale 588
Nazione #
US - Stati Uniti d'America 354
SE - Svezia 54
IT - Italia 41
CN - Cina 27
IE - Irlanda 26
DE - Germania 20
CI - Costa d'Avorio 8
GB - Regno Unito 7
FR - Francia 6
IN - India 6
RU - Federazione Russa 4
SG - Singapore 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
CY - Cipro 2
FI - Finlandia 2
HK - Hong Kong 2
NL - Olanda 2
RO - Romania 2
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
CA - Canada 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
KR - Corea 1
LU - Lussemburgo 1
MY - Malesia 1
PA - Panama 1
ZA - Sudafrica 1
Totale 588
Città #
Chandler 116
Ashburn 38
Dublin 26
New York 26
Milan 16
Beijing 15
Boston 13
Bremen 12
Hangzhou 12
Princeton 12
Abidjan 8
Boydton 7
London 7
Redwood City 6
Rome 5
San Mateo 5
Wilmington 5
Paris 4
Washington 4
La Paz 3
Redmond 3
Amsterdam 2
Andover 2
Ansbach 2
Brno 2
Chennai 2
Civitella in Val di Chiana 2
Comelico Superiore 2
Fairfield 2
Frankfurt am Main 2
Helsinki 2
Hong Kong 2
Monmouth Junction 2
Nicosia 2
Palazzolo sull'Oglio 2
Pune 2
Augusta 1
Besançon 1
Brdo 1
Brussels 1
Budapest 1
Busto Arsizio 1
Cattolica 1
Centurion 1
Esslingen am Neckar 1
Guaratingueta 1
Jakarta 1
Kochi 1
Kuala Lumpur 1
Laurelton 1
Luxembourg 1
Marseille 1
Montreal 1
Mumbai 1
Munich 1
Norwalk 1
Nuremberg 1
Panama City 1
San Francisco 1
Seoul 1
Sevilla 1
Singapore 1
Timișoara 1
Verdellino 1
Vienna 1
Totale 402
Nome #
Dupilumab improves clinical manifestations, symptoms and quality of life in adult patients with chronic nodular prurigo 51
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 51
Biological agents targeting interleukin-13 for atopic dermatitis 49
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 47
Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy 43
Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib 40
A case of disseminated perforating necrobiosis lipoidica 38
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 35
Leser-Trélat sign as a rare manifestation of cutaneous melanoma 29
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study 28
A case of guttate psoriasis during treatment with dupilumab 26
Annular elastolytic giant cell granuloma following herpes zoster infection 23
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 21
Gianotti-Crosti Syndrome after SARS-CoV-2 infection 17
Successful response to upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab treatment 14
Response to the article by Narla et al “Management of inadequate response and adverse effects to dupilumab in atopic dermatitis” 14
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study 13
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 12
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 10
National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis 10
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation 9
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 9
Polymorphic Skin Eruption in a Middle-Aged Man: A Quiz 9
The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab 9
Head and neck atopic dermatitis: still a challenging manifestation in the biologic era 8
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled 3
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 1
Totale 619
Categoria #
all - tutte 4.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 0 0 2 12
2020/202126 0 0 1 0 2 2 1 12 0 1 6 1
2021/202271 2 0 0 3 4 2 4 6 0 7 18 25
2022/2023287 27 43 16 48 21 31 9 34 45 2 9 2
2023/2024221 9 36 47 27 20 35 23 7 10 7 0 0
Totale 619